Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TODAY Genetics Study

Completed
  • Type 2 Diabetes
    • Little Rock, Arkansas
    • +24 more
    Jul 28, 2021

    Type 2 Diabetes Trial in United States (Rivoglitazone, Pioglitazone, Placebo)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +73 more
    May 6, 2021

    Type 2 Diabetes Trial in United States (Mesenchymal Precursor Cells (MPCs))

    Completed
    • Type 2 Diabetes
    • Mesenchymal Precursor Cells (MPCs)
    • Garden Grove, California
    • +17 more
    Jun 1, 2020

    Type 2 Diabetes Trial in United States (integrated program of nutrition, activity, behavior, and promotion)

    Completed
    • Type 2 Diabetes
    • integrated program of nutrition, activity, behavior, and promotion
    • Irvine, California
    • +7 more
    Apr 28, 2020

    Hyperuricemia, Albuminuria, Type 2 Diabetes Trial in United States (Verinurad 9 mg+Febuxostat 80 mg, Placebo)

    Completed
    Has Results
    • Hyperuricemia
    • +2 more
    • Verinurad 9 mg+Febuxostat 80 mg
    • Placebo
    • Canyon Country, California
    • +17 more
    Dec 18, 2019

    Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Dulaglutide, Insulin glargine, Insulin lispro)

    Completed
    Has Results
    • Type 2 Diabetes
    • Chronic Kidney Disease
    • Montgomery, Alabama
    • +88 more
    Sep 6, 2019

    Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

    Completed
    Has Results
    • Cardiovascular Disease
    • +4 more
    • Lorcaserin hydrochloride
    • Placebo
    • Alexander City, Alabama
    • +498 more
    Jun 27, 2019

    Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

    Terminated
    • Type 2 Diabetes
    • ITCA 650 (exenatide in DUROS)
    • Birmingham, Alabama
    • +50 more
    Mar 4, 2019

    Type 2 Diabetes Trial in Houston (Specialized multidisciplinary diabetes team (SMDT) approach, Traditional model of care)

    Completed
    • Type 2 Diabetes
    • Specialized multidisciplinary diabetes team (SMDT) approach
    • Traditional model of care
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Sep 18, 2018

    Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes Trial in Worldwide (Evolocumab, Placebo to Evolocumab)

    Completed
    Has Results
    • Hypercholesterolemia
    • +2 more
    • Evolocumab
    • Placebo to Evolocumab
    • Tuscumbia, Alabama
    • +65 more
    Aug 2, 2018

    Type 2 Diabetes Trial in United States (ISIS-GCGRRx- Dose Level 1, ISIS-GCGRRx- Dose Level 2, Placebo)

    Completed
    • Type 2 Diabetes
    • ISIS-GCGRRx- Dose Level 1
    • +2 more
    • Greenbrae, California
    • +18 more
    Jun 20, 2018

    Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Mesa, Arizona
    • +78 more
    May 29, 2018

    Obesity, Type 2 Diabetes Trial in Houston (G4H-Diab-Nano)

    Completed
    • Obesity
    • Type 2 Diabetes
    • G4H-Diab-Nano
    • Houston, Texas
      Children's Nutrition Research Center, Baylor College of Medicine
    Feb 19, 2018

    Type 2 Diabetes Trial in Puerto Rico, United States (INCB013739, Placebo comparator matching INCB013739, Metformin)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +67 more
    Feb 12, 2018

    Type 2 Diabetes Trial in Houston (Video Games, Web and DVD knowledge)

    Completed
    • Type 2 Diabetes
    • Video Games
    • Web and DVD knowledge
    • Houston, Texas
      Baylor College of Medicine
    Sep 25, 2017

    Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +138 more
    Mar 29, 2017

    Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin glargine/lixisenatide (HOE901/AVE0010)
    • +2 more
    • Birmingham, Alabama
    • +235 more
    Mar 31, 2017

    Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

    Completed
    Has Results
    • Type 2 Diabetes
    • Insulin glargine/lixisenatide Fixed Ratio Combination
    • +3 more
    • Phoenix, Arizona
    • +272 more
    Mar 31, 2017

    Type 2 Diabetes Trial in Houston (Byetta (exenatide), Symlin (pramlintide))

    Completed
    • Type 2 Diabetes
    • Byetta (exenatide)
    • Symlin (pramlintide)
    • Houston, Texas
      Baylor College of Medicine
    Apr 21, 2017

    Amylin and Incretins on Postprandial Metabolisms in Type 2

    Completed
    • Type 2 Diabetes
      • Houston, Texas
        Baylor College of Medicine
      Apr 21, 2017

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin, Thiazolidinedione (Pioglitazone))

      Completed
      Has Results
      • Type 2 Diabetes
      • Anniston, Alabama
      • +88 more
      Jan 3, 2017

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Metformin XR)

      Completed
      Has Results
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +98 more
      Jan 5, 2017

      Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

      Terminated
      Has Results
      • Type 2 Diabetes
      • Obesity
      • EndoBarrier
      • Sham Procedure
      • Birmingham, Alabama
      • +24 more
      Dec 2, 2016

      Type 2 Diabetes Trial in United States (Bydureon, Placebo)

      Completed
      Has Results
      • Type 2 Diabetes
      • Anaheim, California
      • +28 more
      Dec 5, 2016

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

      Completed
      Has Results
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +328 more
      Dec 2, 2016